Jane Street Group, LLC Tiziana Life Sciences LTD Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.65 - $1.29 $8,431 - $16,732	12,971 New	12,971 $8,000
Q3 2022 Nov 14, 2022	BUY	$0.55 - $0.83 $5,576 - $8,415	10,139 New	10,139 $8,000
Q1 2022 May 17, 2022	SELL	$0.62 - $1.25 $30,652 - $61,798	-49,439 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.89 - $1.66 $44,000 - $82,068	49,439 New	49,439 $47,000

1.94M

19.2K

Ticker TLSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,273,000
Market Cap $95.1M
Description
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.